Your browser doesn't support javascript.
loading
Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial.
Davey, R T; Murphy, R L; Graziano, F M; Boswell, S L; Pavia, A T; Cancio, M; Nadler, J P; Chaitt, D G; Dewar, R L; Sahner, D K; Duliege, A M; Capra, W B; Leong, W P; Giedlin, M A; Lane, H C; Kahn, J O.
Affiliation
  • Davey RT; National Institutes of Health, Bethesda, MD 20892-1880, USA. rdavey@niaid.nih.gov
JAMA ; 284(2): 183-9, 2000 Jul 12.
Article in En | MEDLINE | ID: mdl-10889591
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Interleukin-2 / Anti-HIV Agents Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: JAMA Year: 2000 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Interleukin-2 / Anti-HIV Agents Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: JAMA Year: 2000 Document type: Article Affiliation country: Country of publication: